HGP0608

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HGP0608, covering 2015-06-12 to 2020-11-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia [Phase 3]

See pricing